Document is current
Any future updates will be listed below
-
Authors
Chen, Shimin
Du, Qiaoyun
Yin, Jian
Xu, Xiaoqian
Chen, Wen
Pan, Qinjing
Zhang, Xun
Hong, Ying
Zhang, Wenhua
Liu, Bin
Cui, Jianfeng
Hu, Shangying
Zhao, Fanghui
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82273273)
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 13 May 2025
First Online: 2 June 2025
Declarations
:
: This study was approved by the ethics committees of the Center for Disease Control and Prevention (CDC) in Jiangsu Province, and the Cancer Foundation of China.
: Not applicable.
: Not applicable.
: FZ has granted from GlaxoSmithKline Biologicals, Merck & Co., and Xiamen Innovax Biotech to Cancer Hospital, Chinese Academy of Medical Sciences, to undertake clinical trials on the human papillomavirus (HPV) vaccine.
